Technical Analysis for NUVB - Nuvation Bio Inc.

Grade Last Price % Change Price Change
F 11.37 6.36% 0.68
NUVB closed up 12.64 percent on Tuesday, April 13, 2021, on 44 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical NUVB trend table...

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 6.36%
Wide Bands Range Expansion 6.36%
Oversold Stochastic Weakness 6.36%
New 52 Week Closing Low Bearish 19.81%
Multiple of Ten Bearish Other 19.81%
Wide Bands Range Expansion 19.81%
Oversold Stochastic Weakness 19.81%
Pocket Pivot Bullish Swing Setup 13.70%
Narrow Range Bar Range Contraction 13.70%
NR7 Range Contraction 13.70%
Older End-of-Day Signals for NUVB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA 38 minutes ago
50 DMA Support 38 minutes ago
Gapped Up (Full) 38 minutes ago
Rose Above Previous Day's High 38 minutes ago
Rose Above 50 DMA 38 minutes ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
Classification

Sector: Financial Services
Industry: Shell Companies
Keywords: Biopharmaceutical Cancer Prostate Cancer

Is NUVB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.075
52 Week Low 0.0
Average Volume 946,621
200-Day Moving Average 0.00
50-Day Moving Average 11.13
20-Day Moving Average 11.45
10-Day Moving Average 10.23
Average True Range 0.80
ADX 26.2
+DI 20.83
-DI 29.45
Chandelier Exit (Long, 3 ATRs ) 12.69
Chandelier Exit (Short, 3 ATRs ) 11.65
Upper Bollinger Band 15.00
Lower Bollinger Band 7.91
Percent B (%b) 0.39
BandWidth 61.94
MACD Line -0.49
MACD Signal Line -0.33
MACD Histogram -0.1577
Fundamentals Value
Market Cap 158.88 Million
Num Shares 14.9 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.80
Resistance 3 (R3) 12.60 11.70 12.45
Resistance 2 (R2) 11.70 11.17 11.80 12.33
Resistance 1 (R1) 11.20 10.84 11.45 11.39 12.21
Pivot Point 10.30 10.30 10.43 10.40 10.30
Support 1 (S1) 9.79 9.76 10.05 9.99 9.17
Support 2 (S2) 8.89 9.43 8.99 9.05
Support 3 (S3) 8.39 8.89 8.93
Support 4 (S4) 8.58